Agriculture biotech market seen reaching $214.6 billion by 2031

A new market report projects the global agriculture biotech industry will more than double by 2031, driven by transgenic crops, gene editing and other productivity tools. North America led in 2021, while Asia-Pacific is expected to grow the fastest through 2031.

Why it matters: - Agriculture biotech is becoming a bigger part of how growers improve yields, disease resistance and crop protection. - The market outlook points to rising demand for technologies that can support food supply growth while reducing environmental impact. - The report also highlights a split in regional momentum, with mature markets leading now and Asia-Pacific expanding fastest.

What happened: - Agriculture biotech market size was estimated at $93.1 billion in 2021. - The market is projected to reach $214.6 billion by 2031. - The forecast implies a compound annual growth rate of 8.8% from 2022 to 2031. - Allied Market Research published the report on the global agriculture biotech market covering 2021 to 2031. - The report says crop production held the largest application share in 2021. - The report says Asia-Pacific is expected to post the fastest growth through 2031.

The details: - Growth is being driven by more effective approaches to boost agricultural productivity. - Rapid adoption of biotechnology in transgenic crops is also supporting demand. - The report identifies marker-assisted breeding, gene editing and CRISPR, biosensors, GMO-free RNA interference, 3D bioprinting and biologicals as key technologies. - Marker-assisted breeding helps speed plant-breeding programs by using bioinformatics and genome sequencing to identify markers. - Biosensors are used to monitor metabolic processes in plants and detect disease. - Agriculture biotechnology can improve microbes, animals and plants through DNA-based methods. - Recombinant DNA technology can be used to alter nutritional content in food crops. - Examples cited include soybeans and potatoes with higher protein, amino acid and starch content. - The market is segmented by type into hybrid seeds, transgenic crops, bio-pesticides and bio-fertilizers. - The market is segmented by technology into genetic engineering, tissue culture, embryo rescue, somatic hybridization, molecular diagnostics, vaccine and others. - The market is segmented by application into crop production, crop protection, chemical tolerance, disease resistance and others. - The market is segmented by region into North America, Europe, Asia-Pacific and LAMEA. - North America held more than one-fourth of global revenue in 2021. - Asia-Pacific is projected to grow at a 9.7% CAGR from 2022 to 2031. - The report also notes Europe and LAMEA as part of the regional analysis. - Key companies covered include MITSUI & CO., LTD, KWS SAAT SE & Co. KGaA, Bayer AG, Corteva, Nufarm, Limagrain, Evogene Ltd., Valent BioSciences LLC. and Marrone Bio Innovations. - The companies highlighted strategies including partnership, expansion, collaboration and joint ventures. - The report includes a sample report, a purchase enquiry page and a discount checkout offer.

Between the lines: - The report blends strong growth expectations with clear technology shifts, especially around gene editing, biosensors and biologicals. - Antibiotic-resistance markers remain a constraint because of FDA caution about their use in food development. - Biologics and pheromone-based crop protection are gaining attention because they can work as more targeted alternatives to chemical agrochemicals.

What’s next: - The market is expected to keep expanding as breeders and growers adopt more precision tools. - Asia-Pacific’s growth rate suggests the next phase of demand may come from countries trying to lift output and improve crop resilience. - Companies in the sector are likely to keep leaning on partnerships and joint ventures to build market reach and technical capability.